Related by context. All words. (Click for frequent words.) 65 accumulate preferentially 64 selectively induce apoptosis 63 targeted antifolate 63 personalized dendritic 62 targets Galectin receptors 62 polysaccharide polymer 61 SMIP 61 Alfacell proprietary ribonuclease 60 PORxin TM 60 SinuNase ™ 60 regulate therapeutically important 60 carbohydrate polymer 59 targeted radiotherapeutic 59 acid phosphatase PAP 59 HuCNS SC ® 58 Nektar proprietary 58 selectively inhibit 58 NeoLipid TM 58 Trofex ™ 58 Trofex 58 RH1 targeted chemotherapeutic agent 58 PDX pralatrexate 58 TransVax tm 58 Panzem R NCD 57 prostate cancer antigen prostatic 57 NeoLipid R 57 chemokine receptors 57 Anticalins R 57 Receptors GPCRs 57 G Protein Coupled 57 histone deacetylase HDAC 57 selectively inhibited 57 M# rationally 57 novel L DOS# 57 JAK1 57 CD# expressing 57 preferentially bind 57 orally administered inhibitor 57 PI3K/mTOR 57 PI3K/Akt pathway inhibitor 57 anti atherothrombotic 56 isoform selective inhibitors 56 oral picoplatin 56 small molecule tyrosine 56 MCSP respectively 56 autologous cellular therapy 56 potently inhibited 56 ARRY # 56 Company novel nanoviricide 56 potently inhibit 56 enhance ApoA 56 proprietary polysaccharide 56 ATRA IV 55 novel peptide 55 non porcine pancreatic 55 mertansine 55 essential thrombocythemia ET 55 osteogenic 55 NexVas TM 55 potent antiproliferative 55 candidate REP# 55 BHT DNA 55 antimitotic 55 AVI antisense 55 candidates Azedra TM 55 Immunotherapeutic 55 5 HT2A inverse 55 hematopoietic stem 55 molecular imaging radiopharmaceuticals 55 OvaRex R 55 MTP inhibitor 55 cytotoxic antibody 55 thrombin component 55 investigational humanized monoclonal antibody 55 hyaluronidase enzyme 55 please visit www.advaxis.com 55 HepDirect 54 small molecule chemotherapeutic 54 GVAX ® 54 Acetavance TM intravenous acetaminophen 54 5 HT6 54 HepDirect R 54 proprietary Isolagen Process 54 peptidomimetic 54 cytolytic 54 Thalomid R 54 hypoxia activated prodrug 54 candidate deforolimus 54 treats acute lymphoblastic 54 potently inhibits 54 eTag assays 54 Reports Preclinical Data 54 TLR8 agonist 54 Gamma secretase 54 INxin 54 liposomal formulation 54 5 HT2A serotonin 54 Canvaxin TM 54 Protein Kinase C 54 humanized therapeutic 54 Panzem ® 54 CoVal TM fusion 54 adenosine A2A 53 selectively inhibit replication 53 Locked Nucleic Acid LNA 53 specific lectin receptors 53 KSP inhibitor 53 intranasal insulin product 53 ZFP Therapeutics 53 JAK#/JAK# 53 detection reagents 53 AAG geldanamycin analog 53 kidney urologic 53 reversible inhibitor 53 Kinase Inhibitor 53 NEUGENE antisense 53 humanized monoclonal antibodies 53 Maxy G# 53 sapacitabine CYC# 53 dihydrofolate reductase DHFR 53 2 inhibitor CYT# 53 antiproliferative effects 53 platform HDL Mimetic 53 anionic backbone 53 protein receptors lectins 53 Factor Receptor 53 novel emulsion formulation 53 XL# anticancer compounds 53 M2 subunit 53 small molecule agonists 53 avian influenza viral infections 53 human IgG1 monoclonal 53 novel histone deacetylase 53 NOD SCID mice 53 Solazed 53 humanized monoclonal 53 vascular disrupting agents 53 engineered anticoagulant 53 candidate Lovaxin C 53 angina nausea 53 Delta opioid receptor 53 Submits Response 52 molecular chaperone regulation 52 topical agent Xantryl 52 cyclin dependent kinase inhibitor 52 NPC 1C 52 rxRNA 52 neurodegenerative diseases Alzheimer disease 52 detoxify harmful 52 SynCon 52 TÎ ² 4 52 anti CD3 52 molecular chaperone technology 52 initiate Phase IIa 52 Anticalins ® 52 Epigenomics proprietary 52 TRIOLEX HE# 52 neuronal nicotinic receptors NNRs 52 abnormal p# 52 ultrasensitive detection 52 Omacetaxine 52 Factor VIIa 52 selectively modulate 52 inhibit EGFR 52 Novavax VLP vaccine 52 HuMax 52 potent suppressor 52 vaccine GMK 52 t2cure GmbH 52 Initiates Clinical 52 SuperAntibody 52 taxane derivative 52 neovasculature 52 HCV polymerase 52 castrate resistant 52 ENMD # 52 tests miRview TM 52 Monoclonal antibody 52 indications Cytokinetics 52 Chemokine 52 muscarinic receptor agonists 52 please visit www.middlebrookpharma.com 52 clinically validated targets 52 targeting moieties 52 chimeric monoclonal antibody 52 tumor vascular disrupting 52 demonstrated antitumor activity 52 NexVas TM PR 52 bioengineered novel 51 delta isoform 51 GMX# 51 recombinant antibody 51 tubulin inhibitor 51 BrachySil ™ 51 BN# [002] 51 Galectins 51 technology Parthenogenesis 51 injectable biologic 51 HEPLISAV ™ 51 targeting CD# 51 attach auristatin 51 insomnia migraine headaches 51 ghrelin antagonist 51 thrombin receptor 51 microsurgical disciplines 51 Aurora Kinase 51 MSCRAMM R 51 AQ4N 51 pluripotent human 51 liposome encapsulated 51 Salmonella vector 51 carcinoid syndrome diabetes 51 Apoptone HE# 51 InterfeRx 51 P#X# antagonist 51 DNA methylation biomarkers 51 acadesine 51 HepDirect technology 51 HDL Selective Delipidation 51 systemic immunosuppressive drugs 51 ® bortezomib 51 therapeutic peptide 51 recombinant plasma 51 HepDirect prodrug 51 CCR9 antagonist 51 Cathepsin B 51 agonistic human 51 inhibit platelet function 51 CpG island 51 Histone deacetylase 51 VTAs 51 treating neuropathic pain 51 preclinically 51 Anticalin ® 51 XL# inhibits 51 adipose derived regenerative 51 brivanib 51 Trastuzumab DM1 51 Initiates Phase II 51 novel VDA molecule 51 phage display technology 51 Imatinib mesylate 51 trial evaluating PRX# 51 Angiolix 51 syngeneic 51 Dyax phage display 51 selective agonists 51 IAP inhibitor 51 sulfonylhydrazine class 51 Fleximer 51 lymphomas leukemias 51 cervical prostate 51 soluble tumor necrosis 51 Litx 51 XP# XP# 51 HSP# inhibitors 51 substantially excreted 51 agents VDAs 51 IKK epsilon 51 IL #p# 51 antisense inhibitors 51 poly ethylene glycol PEG 51 phosphatidylserine PS targeting 51 CYP#A# CYP#D# 51 mTOR mammalian target 50 mitotic kinesin 50 CCR9 50 MyoCell TM 50 hESC derived 50 anticancer therapeutics 50 novel therapeutic antibodies 50 diagnostic biomarkers 50 mediated inhibition 50 gamma glutamyl 50 orally bioavailable mimics 50 thromboxane A2 50 selective modulator 50 Myolimus 50 Achieves Primary Endpoint 50 biologic therapeutics 50 developing TB4 50 selectively bind 50 PSMA ADC 50 peptibody 50 CA9 SCAN 50 DNA intercalator 50 recombinant antibodies 50 CMV vaccine 50 inhibit angiogenesis 50 targeted diseased tissues 50 anti gastrin monoclonal 50 ESBA# 50 Transfection 50 VIBEX MTX 50 Flt3 50 IMiDs R 50 Cumulase 50 mda 7 50 Hedgehog inhibitor 50 multiplexed assays 50 thyroid hormone receptor 50 Amgen Kyowa Hakko Kirin 50 chemically modify 50 replicon 50 induced phosphorylation 50 Preclinical studies suggest 50 ZFN modified 50 inhibit viral replication 50 stranded LNA 50 hypoxia selective 50 CU NP 50 Vascugel 50 Fc fusion protein 50 Vaxfectin TM 50 Fibroblast Growth Factor Receptor 50 proprietary transdermal 50 radiosensitivity 50 CEA CD# Her2 50 Symadex 50 polyclonal antibody 50 MOVIPREP R 50 apricitabine ATC 50 potent inducer 50 favorable pharmacokinetic 50 initiate multicenter 50 selective immunoproteasome inhibitor 50 delivers sumatriptan 50 EGFR HER2 50 HEK# 50 adult mesenchymal stem 50 Beta catenin pathway 50 transiently transfected 50 nucleic acids proteins 50 cytoprotective 50 small molecule modulators 50 Aeolus Pharmaceuticals Announces 49 untreated metastatic melanoma 49 GVAX cancer 49 prodrugs 49 inhibiting angiogenesis 49 #T# tumor 49 inhibit replication 49 ophthalmology dermatology cardiovascular disease 49 deCODE AF TM 49 gene expression microarrays 49 autologous cellular immunotherapy 49 humanized anti 49 Kosan dependence 49 Oral NKTR 49 protein kinase inhibitors 49 cyclin dependent kinases CDKs 49 ACAPODENE TM 49 Tß4 49 treat musculoskeletal metabolic 49 manufacture PolyHeme 49 Cx# [002] 49 proteins peptides 49 Synuclein 49 mutational status 49 abnormal hematopoietic cells 49 products BioTime develops 49 technological innovations adversely affecting 49 ANGPTL4 49 5 HT4 receptor 49 acetylcholinesterase AChE 49 ribonucleotide reductase clinically validated 49 aurora kinase inhibitor 49 investigational antibody 49 NADiA 49 VeraTag studies 49 Stromal 49 PrevOnco 49 cleavable linker 49 morpholino 49 MKC# MKC# PP 49 potency selectivity 49 genomic biomarker 49 nonviral 49 E2F Decoy 49 lorvotuzumab mertansine 49 Intravenous CP 49 adenoviral 49 next generation URAT1 49 hypoxia inducible factor 49 Potelligent Technology 49 pharmacogenomic translational research 49 ProteomicProcessor 49 proprietary Tissue Repair 49 novel peptides 49 transthyretin TTR 49 Enzastaurin 49 antiangiogenic agent 49 BrachySil TM 49 Alzheimer disease cognitive dysfunction 49 peptidic compound 49 CTAP# Capsules 49 busulfan 49 Proteon Therapeutics Inc. 49 apoptosis proteins 49 neuropathy sparing 49 tezampanel NGX# 49 beta islets 49 polycythemia vera essential thrombocythemia 49 bispecific antibody 49 AIDS prophylaxis congestive 49 heparanase 49 ORE# 49 cytokines chemokines 49 Tesmilifene 49 diagnostic molecular imaging 49 ERalpha 49 ERK pathway 49 neuro protective 49 zinc finger nucleases 49 Pruvel TM 49 basal cell carcinoma squamous 49 siRNA compounds 49 using GIPS SoundWare 49 pro angiogenic 49 cellular immunotherapy 49 Fibroblast 49 CFTR corrector 49 poly ADP ribose polymerase 49 HER2 HER2 49 activin receptor type 49 integrative pharmacology 49 novel oral anticoagulant 49 PDGF receptor 49 inhibits VEGF 49 TRACON Pharmaceuticals 49 IMiDs ® compound 49 CG# [003] 49 humanised monoclonal antibody 49 targeting PCSK9 49 develop electroporation 49 aurora kinase 49 interferon lambda 49 constitutively expressed 49 hybridoma 49 Edward T. Shonsey 49 outlicense 48 Xencor XmAb 48 K ras mutations 48 uricase 48 volociximab 48 MMAE 48 vivo potency 48 thetreatment 48 fibrin derived 48 oral immunomodulatory 48 GKAs 48 induces apoptosis 48 romazarit 48 inhibiting tumor 48 TRAIL receptor 48 5alpha reductase 48 upregulate 48 Urocortin 2 48 Phase IIb clinical trials 48 Adnectin 48 OREXIGEN 48 proprietary BiTE ® 48 CardioVascular BioTherapeutics 48 Gleevec resistant 48 cytotoxic T lymphocyte 48 ResponseDX Lung TM 48 fusion enhancers 48 intracellular uptake 48 alpha#beta# integrin 48 PEGylated interferon 48 experimentally validated 48 RAS RAF MEK 48 Notch inhibitor 48 chemoresistant 48 immatics 48 splice variants 48 hematopoietic progenitors 48 BRAF inhibitors 48 siRNA duplexes 48 VSELs 48 haematologic malignancies 48 figitumumab CP 48 Provacel TM 48 chemokine receptor CCR1 48 CD# ligand 48 DNA methyltransferases 48 oral ghrelin agonist 48 Protein kinase 48 protein tyrosine phosphatase 1B 48 recombinant biopharmaceutical 48 adjuvant GIST 48 p# mitogen activated 48 CRMD# 48 Kinoid 48 PresbyLens ® 48 dermaceutical 48 CCR2 48 antifibrotic 48 carbohydrate compounds 48 engineered proteases 48 non nucleoside polymerase 48 integrin receptor 48 bispecific antibodies 48 HUMIRA resembles 48 Estrogen receptor positive 48 OSI Eyetech 48 Exelixis compounds 48 ImmunoGen proprietary 48 Anticalin 48 HCV antiviral 48 InterfeRx TM 48 Met receptor tyrosine 48 sodium glucose cotransporter 48 Linjeta TM 48 Quark Biotech 48 GEM OS2 48 thymosin beta 4 48 intracellular targeting 48 papillary renal cell carcinoma 48 ETBs 48 vWF 48 tumorigenicity 48 siRNA therapeutic 48 promising anticancer 48 MCF7 48 gallium nitrate injection 48 Pitavastatin 48 oral kinase inhibitor 48 Smac mimetic 48 cisplatin resistant 48 patented Bioral R nanocochleate 48 fibrotic disorders 48 BCL2 48 antiproliferative activity 48 sd rxRNA 48 detect amyloid plaque 48 Extracellular Matrix 48 juvenile chondrocytes 48 cathepsins 48 humanised antibody 48 small molecule glucokinase 48 Raptor preclinical 48 SMIP TM therapeutics 48 GCase 48 Nasdaq HALO biopharmaceutical 48 monoclonal antibody MAb 48 telomerase inhibitor 48 PharmFilm 48 aberrantly activated 48 interleukin IL -# 48 oral Janus kinase 48 modified oligonucleotides 48 bone marrow lymph nodes 48 Smac mimetics 48 mineralocorticoid 48 Alequel ™ 48 selectively inhibiting 48 Tie2 48 factor HGF 48 Upregulation 47 trans splicing 47 Fibrin MB 47 Poly ICLC 47 chemokine receptor 47 delipidation 47 immunomodulation 47 protein tyrosine kinase 47 peptidic 47 biotherapeutic drugs 47 Multi Lineage Progenitor 47 mesenchymal stem cell 47 Cell TRC 47 induce pluripotency 47 Amyloid beta 47 receptor tyrosine kinase inhibitor 47 intracellular protein 47 topoisomerase II inhibitor 47 Prolastin A1PI 47 Unigene patented manufacturing 47 topical anti infectives 47 selective angiogenic kinase inhibitor 47 cystic fibrosis bronchiectasis inhalation 47 1α 47 EGFR pathway 47 RDEA# potent 47 phosphorylated proteins 47 UsiRNAs 47 inverse agonist 47 1beta 47 Eg5 47 factor G CSF 47 type plasminogen activator 47 RIGScan CR 47 anti infective therapeutics 47 nucleic acid molecules 47 Mesenchymal 47 KRAS mutant 47 Y2 receptor 47 proprietary biomaterials 47 Parathyroid hormone 47 lipid nanoparticles 47 developing ViaCyte SM 47 HCD# [002] 47 Th2 cytokines 47 Cytotoxic T 47 c Raf kinase 47 treating peripheral arterial 47 CCR1 47 antisense oligonucleotides 47 VESTASYNC II trial 47 therapeutically relevant 47 retinoic acid receptor 47 CINtec R 47 circulating endothelial cells 47 Chinese Hamster Ovary 47 IGF1R 47 selective kinase inhibitors 47 cathepsin K inhibitor 47 silico predictive discovery 47 nephrology oncology supportive 47 Multipotent 47 Phase #b/#a trial 47 advanced malignant hepatic 47 LHRH receptor positive 47 GLPG# 47 immunoregulatory 47 glucagon receptor 47 apoptosis inducing 47 Peroxisome Proliferator Activated Receptor 47 programs visit http:/www.bionovo.com 47 III EGFRvIII 47 antiviral antibacterial 47 transfect 47 BiTE 47 FGFs 47 DG# compounds targeting 47 eIF 4E 47 therapeutic radiopharmaceuticals 47 Systemic Delivery 47 Protein Expression 47 sequence homology 47 activate p# 47 undergoing hematopoietic stem 47 anti angiogenic drugs 47 inhibitor COX 47 phosphoinositide 47 rALLy clinical trial 47 Cyclosert 47 HepG2 47 tumor suppressor PTEN 47 adipose tissue derived 47 protein tyrosine phosphatases 47 ZFP TF 47 oxidative stress inducer 47 colorectal bladder 47 Peer Schatz QIAGEN 47 descending thoracic 47 Vaxfectin R formulated 47 Additionally MorphoSys 47 ANTISENILIN ® 47 embryonic progenitor 47 short hairpin RNAs 47 pursuing accretive acquisitions 47 dysplastic lesions caused 47 R vitespen 47 Micromet BiTE 47 Interferon beta 47 TGR5 47 Src kinase 47 Triapine R 47 urate oxidase 47 PI3 K 47 M1 muscarinic 47 #beta HSD1 47 antitumoral 47 developing calcitonin 47 AquaMed 47 pathophysiological effects 47 regenerate diseased 47 Transdrug ® nanoparticle 47 deforolimus 46 mitogenic 46 file INDs 46 PrevOnco ™ 46 ADME properties 46 glucocerebroside primarily 46 Benou added 46 RECOTHROM R 46 HuMax TAC 46 deposited preferentially 46 antibiotics antifungals 46 prognostic biomarker 46 lymphoid organs 46 Carfilzomib 46 KinomeScan 46 OncoVex 46 monocytes macrophages 46 Prochymal Chondrogen 46 therapeutics diagnostics 46 FK# 46 DP VPA 46 siRNA conjugates 46 purinergic receptors P#X# 46 Pre RELAX AHF 46 Fibroblast growth 46 Tahir Niaz 46 RAS MAPK pathway 46 Anturol TM 46 multitargeted 46 GRNOPC1 contains 46 Darinaparsin 46 Hemopurifier ® 46 MB# MB# 46 ImmuneY2 46 IFN g 46 sodium glucose transporter 46 AGGRASTAT R tirofiban hydrochloride 46 prostate cancer benign prostatic 46 adipogenic 46 factor TNF receptor 46 tubulin binding 46 AT1R 46 antiangiogenesis 46 Topoisomerase II 46 ErbB3 HER3 46 HER2 ErbB2 46 synthetic peptides 46 Ibis T# 46 folate analogue metabolic 46 Dr. Raafat Fahim 46 potent inhibition 46 Allogeneic 46 cyclic AMP cAMP 46 AFREZZA TM 46 placental derived 46 anti fibrotic 46 INTEGRILIN R eptifibatide Injection 46 StemEx 46 injectable collagenase 46 LEUKINE 46 patented NanoStat ™ 46 adrenoceptor 46 telomerase reverse transcriptase 46 mesenchymal cell 46 carcinoma HCC 46 penetrating peptides 46 p# subunit 46 MDR Gram negative 46 NS5b 46 Ag Cu Pb 46 cortisol synthesis 46 Endotis 46 Hypoxia Inducible Factor 46 commercialize Qutenza 46 human airway epithelial 46 inhibit tumor 46 somatostatin receptor 46 Antitumor 46 Granulocyte Colony Stimulating Factor 46 stably expressing 46 cyclooxygenase COX 46 sNDAs 46 potent activator 46 subsidiaries visit http:/www.apricusbio.com 46 mRNA encoding 46 Ii protein 46 initiate Phase IIb 46 biocatalytic processes 46 NABTT 46 metastatic neuroendocrine tumors 46 keratinocyte 46 p# deficient 46 Hematopoietic 46 hESC derived cardiomyocytes 46 RNAi reagents 46 stimulate insulin secretion 46 photosensitizers 46 transduced 46 HIF 1alpha 46 Undesirable alterations 46 colon carcinoma 46 PharMerica LTC Transaction 46 enzyme inhibitor 46 IL-#/# 46 stably transfected 46 stem cell pluripotency 46 viral protease 46 Antigen Specific 46 radionuclide therapy 46 phosphoprotein 46 carcinoembryonic antigen 46 folate receptor 46 IMPDH 46 synthetic siRNA 46 About Positron Positron 46 allogeneic epidermal 46 NurOwn ™ 46 kappa B 46 progesterone receptor 46 secreted protein 46 hematopoietic progenitor cells 46 Adrenergic 46 FGFR4 46 enzyme beta secretase 46 tryptase 46 prostanoid 46 Te tellurium based 46 Including newbuildings 45 Tarvacin Anti Cancer 45 anaphase promoting complex 45 transfect cell 45 interferon γ 45 TNFR 45 BACcel 45 lysophosphatidic acid LPA 45 enzyme immunoassay EIA 45 Bayer HealthCare Onyx Pharmaceuticals 45 CCL# 45 maturation inhibition 45 infectious autoimmune 45 optical biosensors 45 cytotoxicity assays 45 Evoltra ® 45 Nicotine Conjugate Vaccine 45 intravenous iclaprim potent 45 MSCRAMM 45 gene methylation 45 JAK inhibitors 45 JAK3 45 mobilize hematopoietic stem 45 c MET 45 Levulan ® PDT 45 co stimulatory molecules 45 antisense inhibition 45 ACTCellerate 45 Cobalamin TM mediated 45 HepeX B TM 45 Myoblast Program 45 endosomal release 45 adipose derived 45 mTOR inhibitors 45 rotavirus shingles 45 generation rotary VAD 45 vigabatrin GABA aminotransferase inhibitor 45 CLIRS trial 45 initiate Phase 1b 45 Glucokinase 45 inactivating mutations 45 polymer electrolyte membrane PEM 45 hormone gastrin 45 therapeutic monoclonal antibodies 45 immunotherapeutic approaches 45 HIF PH 45 CRACM 45 potent topoisomerase II 45 ERK1 2 45 cyclin dependent kinase CDK 45 prostatic adenocarcinoma 45 IgGs 45 c myb 45 CobaCyte 45 fluorescent nanocrystals 45 glucokinase 45 workflow toolsets 45 proprietary MSCRAMM protein 45 VEGF receptor 45 DEEP AF 45 small molecule activators 45 microenvironmental conditions 45 Transdermal Delivery 45 plasmid encoding 45 Integrins 45 hypereosinophilic syndrome 45 Provecta TM 45 incyclinide 45 regenerative therapy 45 androgen receptor AR 45 multipotent adult 45 Hepatocytes 45 inhibiting enzymes 45 CTLs 45 carbohydrate polymers 45 c myc gene 45 mesangial 45 JAK inhibitor 45 Daryl Regier 45 bifunctional 45 porcine derived 45 rat hepatocytes 45 FavId 45 POTELLIGENT R 45 developing vascular disrupting 45 inhibiting viral replication 45 ReCyte 45 Genz # 45 metalloproteinase 45 Lrp5 45 haematopoietic 45 PKC alpha 45 paraffin embedded 45 solubilizing 45 downregulate 45 druggable targets 45 Bruton tyrosine kinase 45 proapoptotic 45 pharmacodynamic effects 45 recombinant soluble 45 tolerogenic 45 TAT Bim 45 Vaxfectin R 45 body AVI antiviral 45 chemo resistant 45 cMET 45 pancreatic adenocarcinoma 45 surgically resected 45 NexGenix 45 p# biomarker 45 ACTCellerate TM 45 serine protease 45 please visit www.rosettagenomics.com 45 Divigel R 45 reproducible quantitative multiplexed 45 develops enhanced ADCC 45 secreted proteins 45 anti neoplastic 45 pain palliation 45 activatable 45 florbetaben 45 sirtuin modulators 45 HDAC6 45 autologous peripheral 45 soluble TNF receptor 45 OLIGON technology 45 destroy cancerous cells 45 iPS derived 45 anterior pituitary 45 Therapeutic antibodies 45 included Raf kinase 45 annexin 45 uses NEUGENE antisense 45 commercialize ZYFLO CR 45 mTOR kinase 45 viral polymerase 45 antigen identification 45 transplanted embryonic 45 Sertoli cell 45 Puricase PEG uricase 45 thymidylate synthase TS 45 Tissue Factor 45 cytotoxic agents 44 website www.internationalstemcell.com 44 somatostatin receptors 44 Landfill Methane Outreach 44 Clusterin 44 albumin binding 44 cytokines IL 44 clade B 44 glycosylated 44 CD#c 44 5 HT2C receptor 44 TXNIP 44 initiate Phase 2b 44 microRNA biomarkers 44 cytolytic activity 44 nucleoside tide 44 modulate 44 MMP2 44 esophageal gastric 44 NP2 Enkephalin 44 hMG 44 miR #a [001] 44 neuroinflammatory 44 Crucell genetically engineered 44 U1 Adaptors 44 cytochrome P# enzymes 44 includes TOLAMBA TM 44 peptide receptor 44 antiangiogenic 44 R baclofen 44 mouse mammary 44 CD3 + 44 pharmacodynamic endpoints 44 metabolomic profiling 44 metabolomic profiles 44 PD2i ® algorithm 44 mRNA sequences 44 Patients administer LEVADEX 44 gamma amino butyric 44 upregulates 44 Rexahn reliance 44 DU# [002] 44 iTRAQ 44 pretransplant 44 cell adhesion molecule 44 commercialize lorcaserin 44 FBPase 44 tubulin inhibitors 44 www.aastrom.com 44 safety tolerability pharmacodynamics